Management of Acute Left Ventricular Failure with Hypotension

Initial Assessment and Management

The European Society of Cardiology recommends confirming cardiogenic shock diagnosis, defined as systolic blood pressure <90 mmHg for >30 minutes despite adequate volume status with signs of hypoperfusion, such as oliguria, altered mentation, cool extremities, and blood lactate elevation 1
The European Society of Cardiology suggests assessing fluid status before initiating vasopressors or inotropes, and administering a fluid challenge if hypovolemia is suspected 2
Continuous monitoring of heart rate, rhythm, blood pressure, oxygen saturation, fluid intake/output, daily weight, jugular venous pressure, and extent of pulmonary/peripheral edema is recommended by the European Heart Journal for at least the first 24 hours 3

The European Society of Cardiology recommends norepinephrine as the first-line vasopressor for hypotension in acute left ventricular failure, with a starting dose of 2-3 ml/minute (8-12 mcg/minute) and titration to maintain systolic BP 80-100 mmHg 1
The American College of Cardiology suggests adding dobutamine for patients not on beta-blockers if low cardiac output persists despite norepinephrine, and considering levosimendan for patients on chronic beta-blocker therapy 1, 4
The European Society of Cardiology recommends avoiding vasodilators (nitrates, nitroprusside) in patients with systolic BP <90 mmHg, as they can further reduce organ perfusion 5
The American College of Cardiology suggests continuing ACE inhibitors/ARBs and beta-blockers only if hemodynamically stable, and reducing or temporarily discontinuing otherwise 2, 4
The American Heart Association recommends using diuretics cautiously in hypotensive states and temporarily discontinuing until blood pressure stabilizes 4, 6

The European Society of Cardiology recommends transferring patients with refractory cardiogenic shock rapidly to a tertiary care center with 24/7 cardiac catheterization capability and dedicated ICU with mechanical circulatory support availability 1
The European Society of Cardiology suggests considering short-term mechanical circulatory support based on patient age, comorbidities, neurological function, and response to pharmacological therapy 1
The European Society of Cardiology recommends against the routine use of intra-aortic balloon pump (IABP) in cardiogenic shock based on current evidence 1

The European Heart Journal recommends continuing monitoring of heart rate, rhythm, blood pressure, and oxygen saturation for at least 24 hours, and daily assessment of fluid status, including intake/output, weight, jugular venous pressure, and extent of pulmonary/peripheral edema 3
The European Heart Journal suggests monitoring blood urea nitrogen, creatinine, potassium, and sodium daily during IV therapy, and ensuring resolution of the acute episode, absence of congestion, stable oral diuretic regimen, and optimization of long-term disease-modifying therapy before considering discharge 3

The European Society of Cardiology recommends avoiding vasodilators when systolic BP <90 mmHg, as this can worsen hypotension and organ perfusion 5
The European Society of Cardiology suggests avoiding routine use of opioids in acute heart failure patients, as they may be associated with higher rates of mechanical ventilation, ICU admission, and mortality 2
The American College of Cardiology recommends against using parenteral inotropes in normotensive patients with acute decompensated heart failure without evidence of decreased organ perfusion 4